Skip to content
2000
Volume 9, Issue 7
  • ISSN: 1389-5575
  • E-ISSN: 1875-5607

Abstract

There is compelling evidence that treatment with 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase inhibitors - “statins” - the most important class of lipid lowering agents, reduces ischemic stroke incidence independent on their effect on serum cholesterol levels. In this review, the non-lipid-mediated - “pleiotropic” - effects of statins as well as their potential implication in developing new treatment strategies for stroke prevention will be discussed.

Loading

Article metrics loading...

/content/journals/mrmc/10.2174/138955709788452658
2009-06-01
2025-09-25
Loading full text...

Full text loading...

/content/journals/mrmc/10.2174/138955709788452658
Loading

  • Article Type:
    Research Article
Keyword(s): HMG-CoA reductase inhibitors; pleiotropic effects; stroke
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test